Future Outlook: Research and Emerging Therapies for Primary Sclerosing Cholangitis
Why Finding a Cure is Challenging
PSC is rare and has a complex, multifactorial origin. Its unpredictable course, silent progression, and diverse presentation make large clinical trials difficult. However, progress is being made on many fronts.
Current Treatments and Limitations
Currently, no FDA-approved medication halts Primary Sclerosing Cholangitis progression. Symptomatic treatments and liver transplants are the primary options. But research is shifting toward disease-modifying therapies.
Primary Sclerosing Cholangitis Market
https://www.coherentmarketinsi....ghts.com/market-insi
#primarysclerosingcholangitis, #liverhealth, #pscawareness,
#chronicliverdisease, #autoimmuneliverdisease, #coherentmarketinsights.
